Norethindrone And Ethinyl Estradiol Kit
Product Images NDC 79929-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol (NDC 79929-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-11.jpg (Blister 11)

Blister-11.jpg (Blister 11)
This appears to be a label for a medication called Norethindrone and Ethinyl Estradiol Tablets with a strength of 1mg/0.035mg. The label reminds the user to place the correct day label for a 28-day cycle and store the medication at a temperature range of 15°C to 30°C (59°F to 86°F) and away from children.*
FDA Label Image

Blister-22 (Blister 22)

Blister-22 (Blister 22)
This is a label for Norethindrone and Ethinyl Estradiol tablets. The label indicates the correct day for consumption needs to be placed. It recommends storing the tablets at a temperature range of 15°C to 30°C and warns to keep it out of reach of children.*
FDA Label Image

Blister-33 (Blister 33)

Blister-33 (Blister 33)
This appears to be a label for a birth control pill pack. The brand name is not mentioned, but it contains Norethindrone and Ethinyl Estradiol. The label instructs to place the correct day label on the pill pack and store it between 15°C to 30°C (59°F to 86°F). The pack should be kept out of reach of children.*
FDA Label Image

Figure-2 (Figure2)

Figure-2 (Figure2)
This text summarizes several studies conducted between 2002 and 2017 on the use of combined oral contraceptives and the risk of breast cancer. The studies are mostly cohort studies and have evaluated both ever use and current use of oral contraceptives. The text provides the name and year of each study, along with the effect estimate in odds ratio or relative risk.*
FDA Label Image

Figure 1 (Nor Ethi Fig1)

Figure 1 (Nor Ethi Fig1)
This appears to be a table showing mortality rates per 100,000 woman-years in relation to smoking status (smokers vs non-smokers) and age groups. The table appears to be incomplete as there are no values provided for the mortality rates. It is difficult to provide a more detailed description without the missing information.*
FDA Label Image

Chemical Structure (Nor Ethi Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.